 CARLSBAD, Calif., Dec. 28, 2020 GLOBE NEWSWIRE -- GenMark Diagnostics, Inc. NASDAQ: GNMK GenMark or the Company, a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in two upcoming investor conferences. 